Skip to main content

FDA Warns Eye Drops From Major Brands May Cause Infection

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

MONDAY, Oct. 30, 2023 -- Federal regulators are warning consumers to stop using eye drops and gels from several major brands after finding unsanitary conditions in a manufacturing plant.

Twenty-six eye care products are part of the alert. Those concerning the U.S. Food and Drug Administration are branded CVS Health, Leader (Cardinal Health), Rugby (Cardinal Health), Rite Aid, Target Up & Up, and Velocity Pharma. The FDA urged the manufacturer to recall all lots of these products. CVS, Rite Aid, and Target are pulling products from shelves and websites.

Although there were no reports of infection, bacterial tests were positive in critical drug product areas of the plant. Patients and providers should report any issues to the FDA.

These are not the first in recent reports of unsanitary conditions at facilities making eye care products.

EzriCare Artificial Tears and Delsam Pharma Artificial Eye Ointment were linked to a drug-resistant strain of the bacterium Pseudomonas aeruginosa, leading the FDA and U.S. Centers for Disease Control and Prevention to warn consumers to stop using them in January. That situation was linked to at least four deaths and vision loss in 14 patients.

Then, in March, Canadian drug company Apotex recalled prescription eye drops after some developed cracks in the bottle caps.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

AI Shows Good Clinical Knowledge, Reasoning for Eye Issues

FRIDAY, April 26, 2024 -- Large language models (LLMs) are approaching expert-level knowledge and reasoning skills in ophthalmology, according to a study published online April 17...

ACP: Next-Generation Antibiotics Underused for Gram-Negative Infections

MONDAY, April 22, 2024 -- Clinicians frequently treat gram-negative infection with older, generic antibiotics, despite recent approval of next-generation, gram-negative...

H. Pylori Testing Feasible for People in Community Settings

THURSDAY, April 18, 2024 -- Community Helicobacter pylori (HP) testing in high-risk individuals is technically feasible, according to a study published online April 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.